HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 304: | Line 304: | ||
|Acute myeloid leukaemia with KMT2A rearrangement | |Acute myeloid leukaemia with KMT2A rearrangement | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 312: | Line 312: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | ||
| | |Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | ||
| | |Complete | ||
| | |03/01/2021-MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 328: | Line 328: | ||
| | | | ||
| | | | ||
|Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | |||
|Gordana Raca MD PhD, University of Southern California, Los Angeles | |||
|Complete | |||
| | | | ||
| | |Need permission for figure? Update WHO? | ||
|- | |- | ||
|Acute myeloid leukaemia with NUP98 rearrangement | |Acute myeloid leukaemia with NUP98 rearrangement | ||
| Line 344: | Line 344: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Acute myeloid leukaemia with NPM1 mutation | |Acute myeloid leukaemia with NPM1 mutation | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 360: | Line 360: | ||
| | | | ||
| | | | ||
|Acute Myeloid Leukemia (AML) with Mutated NPM1 | |||
|Xinjie Xu, PhD, FACMG | |||
|Complete | |||
| | | | ||
| | |Add WHO reference | ||
|- | |- | ||
|Acute myeloid leukaemia with CEBPA mutation | |Acute myeloid leukaemia with CEBPA mutation | ||